Bioequivalence Limit, Power and interpretation [Regulatives / Guidelines]

posted by Pharma_88 – India, 2020-09-22 15:27 (1604 d 19:39 ago) – Posting: # 21930
Views: 4,016

Dear All,

I just want basic information about Bioequivalence limit with respect to power and number of subjects.
  1. What to conclude if we got the result where study is failed in lower side i.e. below 80%...
  2. What to conclude if we got the result where study is failed in upper side i.e. above 125%...
  3. What to conclude where study's post hoc power is less then 80 or 85%?

What are the main factors associated with apart from human or instrument error?

Thanks.

Dr. Pharma88

Complete thread:

UA Flag
Activity
 Admin contact
23,380 posts in 4,914 threads, 1,661 registered users;
38 visitors (0 registered, 38 guests [including 3 identified bots]).
Forum time: 10:06 CET (Europe/Vienna)

Everything is trivial, if you know the answer.    Thomas Jaki

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5